News

Freudenberg Medical's New Facility in Ireland Adds 250 Jobs

Freudenberg Medical's New Facility in Ireland Adds 250 Jobs

Freudenberg Medical Expands Operations with New Facility

Freudenberg Medical, a prominent global design and manufacturing partner for minimally invasive medical devices, has celebrated a significant milestone with the expansion of its facility in Ireland. This expansion will not only enhance their operational capacity but also create 250 new job opportunities for the local workforce as they officially opened the upgraded site in Carrick-on-Shannon.

Strategic Development in the Medical Device Sector

Freudenberg Medical operates as part of the larger Freudenberg Group, which has established itself as a key player in the medical device and biopharma industry. With locations spread across the US, Europe, Asia, and Costa Rica, the company is well-positioned to meet rising global demands.

Facility Expansion Details

At the helm of the opening ceremony was Dr. Mohsen Sohi, CEO of the Freudenberg Group. The expanded facility adds an impressive 16,500 square feet, increasing the total operational space in Co. Leitrim to 157,000 square feet. As a result, the total workforce in Carrick-on-Shannon will exceed 950 by 2026, marking a substantial increase of over a third from current staffing levels.

Enhancing Capabilities

This expansion responds to the surging global market for catheter solutions and medical products. The innovations introduced will allow the company to deliver the next generation of catheter technologies more efficiently to its clients. Freudenberg Medical has earned a reputation for producing advanced catheters utilized in vital medical fields such as electrophysiology, structural heart treatments, and peripheral vascular therapies.

Workforce Growth and Community Commitment

Currently, Freudenberg Medical employs over 1,000 people in Ireland. The company ships more than 16 million complex catheters annually, backed by a vast manufacturing area of 200,000 square feet across its facilities in both Co. Leitrim and Co. Galway. Recently, the facility in Galway underwent a 50% expansion, adding an additional 100 jobs to their local community.

Leadership Perspectives

Dr. Mark Ostwald, CEO of Freudenberg Medical, emphasized the significance of this expansion. He articulated that Ireland has established itself as a key hub in life sciences, providing valuable support to Freudenberg Medical's global operations. With a history of 25 productive years in Ireland, the new investment aims to further enhance the company's operational capabilities and reaffirm its commitment to delivering innovative medical solutions.

Barry Regan's Insights

Barry Regan, Vice President and General Manager of Freudenberg Medical’s Co. Leitrim facility, shared his pride in the achievement: "Our Carrick-on-Shannon team is dedicated to meeting the increasing demand for quality medical products. This expansion is not only about increasing capacity; it showcases our commitment to maintaining our reputation as a global leader in the industry." The addition of 250 new jobs highlights the team's hard work and dedication.

Job Recruitment and Opportunities

Recruitment efforts for these newly announced positions are already in progress. The company is seeking qualified candidates across various roles, including engineering, research and development, manufacturing operations, and support services. Interested applicants are encouraged to explore opportunities with Freudenberg Medical as they enhance their operations.

Company Background

Freudenberg Medical plays a crucial role in the medical device landscape, specializing in the design and manufacturing of essential devices and components. Their product range includes complex catheters, hypotubes, needles, and precision molded components. With 11 manufacturing locations worldwide and over 2,800 dedicated associates, Freudenberg Medical exemplifies innovation and excellence in production.

Future Outlook of the Freudenberg Group

A member of the esteemed Freudenberg Group, the company operates under a strategic vision focused on long-term innovations that benefit customers and society alike. Operating across diverse markets, the Freudenberg Group continually invests in research and development to harness its technological strengths. With a rich history spanning 175 years, the group remains committed to principles of reliability, excellence, and responsible action as it supports a workforce of over 52,000 individuals across around 60 countries, generating substantial revenue through its innovative ventures.

Frequently Asked Questions

What is the significance of Freudenberg Medical's expansion?

The expansion of Freudenberg Medical's facility signifies a response to increased global demand and aims to enhance technological capabilities in producing advanced medical devices.

How many new jobs are being created?

Freudenberg Medical has announced the creation of 250 new jobs in Ireland as part of this facility expansion.

What roles are available in the new recruitment drive?

Available roles include positions in engineering, research and development, manufacturing operations, and support services.

How does Freudenberg Medical support the healthcare industry?

Freudenberg Medical provides innovative catheter solutions and components critical to various medical and pharmaceutical applications, reinforcing its position as a trusted partner in healthcare.

What is the broader impact of Freudenberg Group's operations?

The Freudenberg Group focuses on sustainable innovation that strengthens customer support and enhances societal contributions, bolstering their portfolio in numerous markets.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 21

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 6

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading

Top 5 Most Recently Viewed Articles

AIP Realty Trust Announces Successful Non-Brokered Offering

Updated Category News Views 177

AIP Realty Trust's Financial Milestone Achieved AIP Realty Trust has made waves in the investment community by successfully finalizing the initial tranche of a significant non-brokered private placement. These efforts have brought in an impressive total of 7,260,000 Preferred Units—Series B Convertible, valued at US$0.50 each, resulting in gross proceeds of...

Continue Reading
Medtronic's BrainSense™ Receives CE Marking for Parkinson's Care

Updated Category News Views 499

Medtronic’s Innovative Approval for Parkinson's Treatment Medtronic plc (NYSE: MDT), a global leader in healthcare technologies, has achieved a significant milestone by receiving CE Mark approval for its BrainSense™ Adaptive deep brain stimulation (aDBS) system and the BrainSense™ Electrode Identifier (EI). This remarkable advancement introduces the world's first...

Continue Reading
Understanding the New Rating for abrdn Asia-Pacific Income Fund

Updated Category News Views 84

KBRA's Rating Insights on abrdn Asia-Pacific Income Fund Recently, KBRA has taken significant steps by assigning a new rating to the Series B Mandatory Redeemable Preferred Shares (MRPS) of abrdn Asia-Pacific Income Fund, Inc. (NYSE: FAX). This rating stands at 'AA-', illustrating the organization's confidence in the stability and security of these investment instruments....

Continue Reading
Protect Your Investment: Join the Applied Therapeutics Class Action

Updated Category News Views 156

Understanding the Class Action for Applied Therapeutics Investors As an investor in Applied Therapeutics, Inc. (APLT), you may have felt the financial impact of recent challenges the company has encountered. The firm is currently facing a class action lawsuit aimed at addressing securities fraud that adversely affected investors between specific dates. This situation is...

Continue Reading
Heritage Capital Group Facilitates Mittauer's Strategic Sale

Updated Category News Views 205

Heritage Capital Group Facilitates Mittauer's Strategic Sale Heritage Capital Group, Inc. ("Heritage"), a respected investment banking and financial advisory firm known for serving middle-market and emerging growth companies, has successfully guided its client, Mittauer & Associates, Inc. ("Mittauer"), through a significant transition in its business landscape. This...

Continue Reading